BioCardia, Inc. (BCDA) Free cash flow 2017–2025
BioCardia, Inc. (BCDA) annual free cash flow history — operating cash flow minus capital expenditures, per SEC filings.
-$7.4MFY2025 · since FY2017: -$8.8M → -$7.4M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | -$7.4M | +5.7% |
| FY2024 | -$7.9M | +21.0% |
| FY2023 | -$10.0M | +6.1% |
| FY2022 | -$10.6M | -1.4% |
| FY2021 | -$10.5M | +15.4% |
| FY2020 | -$12.4M | -29.2% |
| FY2019 | -$9.6M | +13.9% |
| FY2018 | -$11.1M | -26.4% |
| FY2017 | -$8.8M | — |
Free cash flow = reported operating cash flow − reported capital expenditures for the same fiscal year.
Source: SEC XBRL filings · For reference only · Not investment advice